Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Deficit (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2020 $ 228,347 $ 42,573,272 $ (45,968,839) $ (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974        
Common shares issued for professional fees $ 1,550 112,550 114,100
Common shares issued for professional fees (in Shares) 1,550,000        
Common shares issued for compensation $ 2,700 (2,700)
Common shares issued for compensation (in Shares) 2,700,000        
Common shares issued for accrued compensation $ 945 54,796 55,741
Common shares issued for accrued compensation (in Shares) 944,767        
Common shares issued for cashless warrant exercise $ 1,008 (1,008)
Common shares issued for cashless warrant exercise (in Shares) 1,008,000        
Preferred stock dividends and deemed dividend 2,845,238 (2,855,576) (10,338)
Accretion of stock-based compensation 108,554 108,554
Accretion of stock-based professional fees 5,000 5,000
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 3,778,810 3,778,810
Net loss (4,863,973) (4,863,973)
Balance at Mar. 31, 2021 $ 234,550 49,474,512 (53,688,388) (3,979,326)
Balance (in Shares) at Mar. 31, 2021 234,549,741        
Balance at Dec. 31, 2021 $ 282,217 53,064,616 (57,515,129) 189,255 (3,979,041)
Balance (in Shares) at Dec. 31, 2021 282,216,632        
Common shares issued for accounts payable $ 90 2,084 2,174
Common shares issued for accounts payable (in Shares) 90,859        
Common shares issued for compensation $ 500 13,750 14,250
Common shares issued for compensation (in Shares) 500,000        
Common shares issued for conversion of Series C preferred stock $ 1,543 10,457 12,000
Common shares issued for conversion of Series C preferred stock (in Shares) 1,543,151        
Common stock issued in connection with convertible debt $ 824 12,139 12,963
Common stock issued in connection with convertible debt (in Shares) 823,529        
Preferred stock dividends and deemed dividend (14,005) (14,005)
Accretion of stock-based compensation 42,702 42,702
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation   957,556     957,556
Net loss (1,906,399) (13,020) (1,919,419)
Balance at Mar. 31, 2022 $ 285,174 $ 54,103,304 $ (59,435,533) $ 176,235 $ (4,870,820)
Balance (in Shares) at Mar. 31, 2022 285,174,171